Copyright
©The Author(s) 2023.
World J Gastroenterol. Mar 21, 2023; 29(11): 1745-1756
Published online Mar 21, 2023. doi: 10.3748/wjg.v29.i11.1745
Published online Mar 21, 2023. doi: 10.3748/wjg.v29.i11.1745
Figure 1 Dynamic changes in immunological indicators and liver function in case 1.
A: Trends of anti-A immunoglobulin M (IgM)/immunoglobulin G (IgG) titers and CD4(+) T cell counts over time; B: Trends of liver enzymes over time after liver transplantation. γGT: γ-glutamyltransferase; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; Tbil: Total bilirubin.
- Citation: Tang JX, Zhang KJ, Fang TS, Weng RH, Liang ZM, Yan X, Jin X, Xie LJ, Zeng XC, Zhao D. Outcomes of ABO-incompatible liver transplantation in end-stage liver disease patients co-infected with hepatitis B and human immunodeficiency virus. World J Gastroenterol 2023; 29(11): 1745-1756
- URL: https://www.wjgnet.com/1007-9327/full/v29/i11/1745.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i11.1745